INTRODUCTION
============

Nowadays, the causative microorganism is identified in roughly 90% of the episodes of infectious endocarditis (IE).^[@R1]^ The isolation of more than one microorganism in patients with IE is quite uncommon, ranging from 1% to 6.8%.^[@R2],[@R3]^

Theoretically, polymicrobial infective diseases are associated with a worse clinical course and prognosis than monomicrobial diseases.^[@R4]--[@R6]^ In the case of IE, this hypothesis remains unsettled, because scanty information is available in the literature. Besides, no comparison between polymicrobial endocarditis (PE) and monomicrobial endocarditis (ME) has been undertaken.

Our purpose has been to analyze the clinical, microbiologic, and echocardiographic profile and the outcomes of patients with left-sided PE. We also aimed to compare them with that of patients with ME to establish whether the isolation of more than one pathogen is related to worse prognosis.

METHODS
=======

Study Population
----------------

Since January 1, 1996 to December 31, 2014, all patients with a final diagnosis of IE admitted in three tertiary centers were included in an ongoing multipurpose database. We used the Duke criteria until 2002^[@R7]^ and the modified Duke criteria^[@R8]^ thereafter. All participant hospitals followed a standardized protocol, in which every patient underwent at least 1 physical examination, electrocardiogram, blood analysis, urine analysis, set of 3 blood cultures, and transthoracic and transesophageal echocardiography. We filled a standardized case report form with 26 epidemiological, 72 clinical, 26 laboratory, 6 electrocardiographic, 27 microbiologic, and 68 echocardiographic variables for every patient. The protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the local ethical committees.

To establish the causative microorganism of each episode of IE, we combined both the information of the blood cultures and that obtained from the cultures of biologic infective tissues (ie, explanted valves or prosthesis, embolic material, etc). Patients were divided into 3 groups depending on the number of causative microorganims: PE (2 or more microorganims); ME (one); and unknown microorganism (zero). Patients in whom coagulase-negative *Staphylococci* or other common skin contaminants grew up in the cultures of a biologic infected tissue and not in the blood cultures were excluded from the analysis because contamination could not be ruled out. The main characteristics of PE were compared with those of ME.

Definition of Terms
-------------------

The episode of endocarditis was considered polymicrobial when 2 or more microorganims were cultured in at least 3 blood samples or isolated from infected tissues simultaneously or consecutively within 7 days of the initial positive blood culture without evidence of other clinical infectious foci. Antibiotic treatment and indications of surgery followed the recommendations of the current European guidelines in every moment throughout the study period. Urgent surgery was defined as that performed before the finalization of the antibiotic treatment. If the signs and symptoms of the IE started after 48 hours from the hospital admission or in the first 3 days after discharge or up to 30 days after an operation, the episode was considered as nosocomial. We have analyzed possible predisposing events as situations with theoretical risk of bacteremia occurring within the previous 2 months of the beginning of the disease. Chronic renal disease was defined as a decrease of glomerular filtration rate below 60 ml/min/1.73 m^2^ for at least 3 months. Early prosthetic valve endocarditis was defined as occurring less than 1 year after surgery.^[@R9]^ Other definitions used in this study have been already described in previous works.^[@R10]^

Statistics
----------

Categorical variables are reported as frequency (n) and percentages. Continuous variables as mean ± standard deviation or median and interquartile range (IQR). Normal distribution of quantitative variables was verified with the Kolmogorov--Smirnov test. Qualitative variables were compared with the χ^2^ test and Fisher exact test. Continuous variables were compared with Student *t* test or its equivalent for nonparametric tests, Mann--Whitney *U* test, for variables that were not normally distributed. Data were analyzed using the SPSS V 15.0 software package (SPSS, Chicago, IL).

RESULTS
=======

Epidemiological Features of Polymicrobial Endocarditis
------------------------------------------------------

From January 1, 1996 to December 31, 2014, 1195 episodes of definite IE were diagnosed. Of them, 1011 were left-sided (85%) and formed our study group: 60 were polymicrobial (5.9%), 821 monomicrobial (81.2%), and in 123 patients no microorganism was detected (12.1%). Seven patients (0.7%) were excluded from the analysis because contamination of biologic tissue could not be discarded.

Mean age was 64 years, SD 16 years (IQR: 57--75) and 40 were men (67%). The infection was nosocomial in 18 patients (30%). Of the remaining 42, 34 episodes were community acquired (57%) and 8 healthcare associated (13%). There were 53 patients with previous known cardiac abnormalities (90%): 30 (50%) had prosthetic valves, 12 (20%) degenerative, 5 (8%) rheumatic valvular heart disease, 2 (3%) congenital abnormalities, and 4 (7%) left-ventricular hypertrophy. Previous IE had occurred in 5 patients (8%).

The spectrum of predisposing conditions was as follows: 10 (17%) indwelling intravenous catheters, 9 (15%) previous cardiac surgery, 7 (12%) local infections, 4 (7%) urogenital manipulations, and 3 (5%) dental manipulations. Only 1 patient was intravenous drug user. Finally, 42 patients (70%) had underlying conditions, being diabetes mellitus (35%), and chronic renal failure (17%) the most frequent. Just 1 patient was HIV positive.

Clinical and Echocardiographic Profile of Polymicrobial Endocarditis
--------------------------------------------------------------------

Time of evolution of symptoms to diagnosis was 46 days (IQR 7--61). The most frequent initial symptoms at admission were fever (n = 40; 67%), dyspnea (n = 27; 48%), and shivering (n = 23; 41%). During hospitalization 60% developed heart failure, 45% renal failure, 28% persistent infection, 20% stroke, and 13% cardiogenic shock.

Polymicrobial endocarditis affected native valves in 30 patients (19 mitral, 16 aortic) and prostheses in 30 (16 mechanical mitral prostheses, 8 mechanical aortic, 5 aortic bioprostheses, and 3 mitral bioprostheses). Early-onset prosthetic valve endocarditis occurred in 11 patients (37%) and late onset in 19 patients (63%). There were 12 multivalvular episodes. Transesophageal echocardiograms revealed valvular vegetations in 48 patients (80%) (diameter 18.4 ± 35 × 7.3 ± 4.1 mm; area 0.40 ± 0.6 cm^2^), at least one periannular complication in 13 (22%) (5 abscesses, 8 pseudoaneurysms, and 2 fistulas), and moderate or severe valvular regurgitation in 40 (67%).

Microbiologic Profile of Polymicrobial Endocarditis
---------------------------------------------------

The diagnosis of PE was performed according to the results of blood cultures or serology in 36 patients (60%), with cultures of biologic infected tissues in 7 (12%) and with the combination of both in 17 (28%). Three microorganisms were isolated in 6 patients and 2 in the rest. Coagulase-negative *staphylococci,* enterococci, Gram-negative bacilli and *Staphylococcus aureus* were the predominant pathogens. The microbiologic profile of PE is represented in Figure [1](#F1){ref-type="fig"}. The most frequent combinations of microorganims were: coagulase-negative *Staphylococci* plus enterococci (n = 9, 15%), coagulase-negative *Staphylococci* plus Gram-negative bacilli (n = 5, 8%) and coagulase-negative *Staphylococci* plus *Streptococcus viridans* (n = 5, 8%). A total of 60% of staphylococcal strains were methicillin resistant and there were no streptocococcal strains resistant to penicillin.

![Microbiologic profile of the 60 episodes of polymicrobial left-sided infective endocarditis.](medi-94-e2000-g001){#F1}

Treatment and Outcome of Polymicrobial Endocarditis
---------------------------------------------------

Surgery was performed in 39 patients (65%): urgent in 19 (49%) and elective in 20 (51%). The main indications for urgent surgery were severe valvular dysfunction (45%), heart failure (42%) and persistent infection (42%). Patients received 3.1 ± 0.8 antibiotics for a median of 10 ± 5.7 weeks. Distribution of antibiotics was as follows: glycopeptides (65%), aminoglycosides (60%), penicillins (53%), cephalosporins (25%), carbapenems (10%), and fluoroquinolones (8%). Hospital stay was 49 ± 30 days and total in-hospital mortality 33% (n = 20). Principal causes of death were: uncontrolled infection (25%), heart failure (20%), and hemodynamic instability during extracorporeal circulation (20%).

Comparison Between Polymicrobial and Monomicrobial Endocarditis
---------------------------------------------------------------

Demographic, clinical, echocardiographic, and outcome differences between PE and ME are depicted in Table [1](#T1){ref-type="table"} . Polymicrobial endocarditis appeared more frequently in patients with underlying diseases (70% versus 56%, *P* = 0.04), more often in diabetics (35% versus 24%, *P* = 0.04). It was more frequently prosthetic (50% versus 37%, *P* = 0.04), and healthcare related (19% versus 9%, *P* = 0.046). No differences in other echocardiographic findings were found. Coagulase-negative *Staphylococci,* enterococci, Gram-negative bacilli, anaerobes, and fungi were more frequent in PE (Table [2](#T2){ref-type="table"}). Among *Staphylococcal* species, methicillin resistance was more frequent (60% versus 39%, *P* = 0.028) in PE. The number of antibiotics prescribed (3.1 ± 0.8 versus 2.7 ± 1, *P* = 0.002) and the use of glycopeptides (65% versus 46%, *P* = 0.005) were also higher in PE, but the duration of the antibiotic treatment was similar. No differences in the need of surgery (65% versus 59%, *P* = 0.39) and mortality (33% versus 30%, *P* = 0.61) were observed.

###### 

Demographic, Clinical, Echocardiographic and Outcome Differences Between Polymicrobial and Monomicrobial Endocarditis

![](medi-94-e2000-g002)

###### 

Demographic, Clinical, Echocardiographic and Outcome Differences Between Polymicrobial and Monomicrobial Endocarditis

![](medi-94-e2000-g003)

###### 

Comparison of the Microbiologic Profile Between Polymicrobial and Monomicrobial Endocarditis

![](medi-94-e2000-g004)

DISCUSSION
==========

Polymicrobial diseases, which are recognized with increasing frequency, are acute and chronic diseases caused by various combinations of viruses, bacteria, fungi, and parasites.^[@R11]^ It is known that the presence of 1 microorganism can generate a niche for other pathogenic microorganisms to colonise.^[@R12],[@R13]^ In the particular case of PE, scanty data is available, only case reports,^[@R11],[@R14],[@R15]^ small series^[@R16]--[@R18]^ and a systematic review in 1991^[@R19]^ have been reported.

Our investigation, to our knowledge, is the first prospectively recruited series, which depicts the current characteristics of PE, and compares them with those of ME. Our results shed light on this topic, which has been systematically left out when IE has been analyzed.

Some important consequences can be drawn from the investigation herein presented: prevalence of PE in our series is higher than previously reported; coagulase-negative *Staphylococci, enterococci,* Gram-negative bacilli, anaerobes, and fungi are more frequently encountered as causative pathogens in PE; staphylococcal strains were more frequently methicillin resistant in PE; but in spite of all these differences, the clinical profile and the prognosis are very similar. Any of these findings deserves a comment.

Epidemiology and incidence of PE has not been determined. In older studies, PE affects predominantly drug abusers and patients with valvular prosthesis,^[@R15]--[@R24]^ and the incidence was reported ranging from 1% in unselected populations to 6.8% in drug users,^[@R2],[@R3]^ although nowadays it could be higher.^[@R18]^ Our work shows an incidence of 5.9% and only 1 patient was drug addict. This difference with previous older studies can be explained by 3 facts. First, the definition of PE used in our study. We not only considered the results of the blood cultures, but also the cultures of infected tissues related to the endocarditis, for example the valves, prosthesis or embolic material explanted during surgery. In fact, in 40% of our PE patients the diagnosis was performed taking into account these cultures. Other explanation might be the progressive improvement in the microbiologic techniques, which have incremented the sensitivity to detect microorganisms.^[@R25]--[@R27]^ Lastly, we have excluded right-sided endocarditis from our study. Our incidence would have been higher (6.6%) if 7 patients with coagulase-negative *Staphylococci* in the cultures of biologic material had been included, but as the possibility of contamination could not be ruled out, we decided to exclude them from the analysis.

Several reasons are behind the microbiologic profile of PE in our series. The high proportion of prosthetic episodes, the frequent association with underlying diseases, as diabetes mellitus, or the association with healthcare exposure can explain that coagulase-negative *Staphylococci* are the leading cause of PE, and the high proportion of methicillin resistant staphylococcal strains. In fact, they are the most common microorganisms isolated in early-onset prosthetic valve IE^[@R28]^ but also in blood cultures as result of contamination.^[@R29]^ Taking into account this last consideration, we only considered them as etiologic agents of the episode of IE when they were isolated in three consecutive blood cultures, excluding those cases with only isolation in biologic infected tissues. Enterococci, which are reportedly the third most common group of IE-causing pathogens,^[@R30]^ are the second main etiology of PE. They share with *staphylococci* a high capacity of adhering to the endocardium, fibrin, and platelets.^[@R31]--[@R37]^ Theoretically, synergy between these microorganisms may also favor the infective pattern herein found. Nevertheless, there is little clinical evidence that synergy is important to the pathogenesis of IE. It is noteworthy that anaerobes were cultured in almost 20% of PE, whereas in ME their prevalence was anecdotal. It is well known that polymicrobial infections usually involve anaerobes,^[@R38]^ and many mechanisms explaining this synergy have been proposed; inhibition phagocytosis of aerobes by leukocytes, provision of essential nutrients, such as vitamin K, succinate, and various growth factors, alteration of local environment, including reduction of the oxygen tension and lowering of redox potential and provision of substances toxic to the host that permit species of bacteria to flourish concurrently.

Finally, it has to be emphasized that clinical characteristics of PE did not differ substantially from ME and more importantly, the presence of more than one pathogen in cultures does not adversely affect prognosis. A small retrospective investigation had already suggested a similar outcome of both groups of patients.^[@R39]^ In this regard, a recent prospective study in critically ill patients at an intensive coronary care unit further supports our results^[@R40]^ no differences in mortality were seen between 75 patients with polymicrobial bloodstream infection and 371 with monomicrobial. Therefore, from a practical standpoint, the management and the therapeutic strategy of patients with IE should be the same irrespective of whether the patient has PE or ME.

In conclusion, incidence of left-sided PE is higher than previously reported. Despite PE has a specific epidemiologic and microbiologic profile, its clinical course and prognosis are similar to that of ME.

Abbreviations: HIV = human immunodeficiency virus, IE = infective endocarditis, ME = monomicrobial endocarditis, PE = polymicrobial endocarditis.

The authors have no conflicts of interest to disclose.
